Meier Richard A Insider Trades

Insider Trading History

Track insider trading activity for Meier Richard A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $7.2M 127,426 shares
Last Trade
May 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$399k 6,650 shares
$59.93
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $6.82M 120,776 shares
Last Trade
Jun 03, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$417k 5,451 shares
$76.41
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $0 0 shares
Last Trade
Jun 03, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$504k 6,600 shares
$76.41
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $7.13M 126,227 shares
Last Trade
Jun 03, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$504k 6,600 shares
$76.41
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $6.76M 119,627 shares
Last Trade
May 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$548k 7,080 shares
$77.34
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $6.36M 112,547 shares
Last Trade
Jan 08, 2024 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$297k 3,000 shares
$99.00
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $6.53M 115,547 shares
Last Trade
May 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$385k 4,190 shares
$91.99
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $0 0 shares
Last Trade
May 12, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$798k 8,500 shares
$93.93
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $6.29M 111,357 shares
Last Trade
May 12, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$576k 6,137 shares
$93.93
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $6.64M 117,494 shares
Last Trade
May 12, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$798k 8,500 shares
$93.93
$56.50
Rockley Photonics Holdings
Rockley Photonics Holdings RKLY
President & CFO
Holding Value $364k 1,891,521 shares
Last Trade
Oct 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.18M 1,891,521 shares
$0.63
$0.19
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $6.16M 108,994 shares
Last Trade
May 24, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$392k 4,980 shares
$78.78
$56.50
Intersect ENT
Intersect ENT XENT
EVP & Chief Financial Officer
Holding Value $0 0 shares
Last Trade
May 13, 2022 Sale (Tender)Reported as Tender on SEC Form 4.
$7.02M 272,448 shares
$25.78
$28.24
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $6.1M 107,892 shares
Last Trade
May 02, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$708k 8,500 shares
$83.31
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $5.88M 104,032 shares
Last Trade
May 02, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$317k 3,860 shares
$82.09
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $0 0 shares
Last Trade
May 02, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$708k 8,500 shares
$83.31
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $0 0 shares
Last Trade
May 02, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$708k 8,500 shares
$83.31
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $5.88M 104,014 shares
Last Trade
May 02, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.48k 18 shares
$82.12
$56.50
Intersect ENT
Intersect ENT XENT
EVP & Chief Financial Officer
Holding Value $4.62M 163,596 shares
Last Trade
Feb 02, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$63.6k 2,329 shares
$27.31
$28.24
Intersect ENT
Intersect ENT XENT
EVP & Chief Financial Officer
Holding Value $4.69M 165,925 shares
Last Trade
Feb 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1M 36,738 shares
$27.30
$28.24

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up